Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).

F. Merabet, N. Boissel, O. Reman, Jean-Henri Bourhis, B. Quesnel, S. Rigaudeau, C. Cordonnier, D. Bordessoule, H. Tilly, S. Corm, M. Michallet, J.M. Miclea, X. Thomas, S. Chevret, P. Fenaux, S. Castaigne

Blood (2007) 110 (11): 1857.

https://doi.org/10.1182/blood.V110.11.1857.1857

Published: 2007

Journal Articles

Trisomy 4, a New Chromosomal Abnormality in Waldenstrom’s Macroglobulinemia.

C. Terre, F. N. Guyen-Khac, C. Barin, M.J. Moziconacci, V. Eclache, C. Leonard, H. Farhat, A. Bouyon, P. Rousselot, S. Choquet, V. Leblond, S. Castaigne

Blood (2005) 106 (11): 2841.

https://doi.org/10.1182/blood.V106.11.2841.2841

Published: 2005

Journal Articles

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

Blood (2005) 106 (11): 890.

https://doi.org/10.1182/blood.V106.11.890.890

Published: 2005

Journal Articles

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

L Degos, H Dombret, C Chomienne, MT Daniel, JM Miclea, C Chastang, S Castaigne, P Fenaux

Blood (1995) 85 (10): 2643–2653.

https://doi.org/10.1182/blood.V85.10.2643.bloodjournal85102643

Published: 1995

Journal Articles

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

P Fenaux, E Wattel, E Archimbaud, M Sanz, B Hecquet, N Fegueux, A Guerci, H Link, M Fey, S Castaigne

Blood (1994) 84 (2): 666–667.

https://doi.org/10.1182/blood.V84.2.666.666

Published: 1994

Journal Articles

Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells

C Dubois, MH Schlageter, A de Gentile, F Guidez, N Balitrand, ME Toubert, I Krawice, P Fenaux, S Castaigne, Y Najean

Blood (1994) 83 (11): 3264–3270.

https://doi.org/10.1182/blood.V83.11.3264.3264

Published: 1994

Journal Articles

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

S Castaigne, P Lefebvre, C Chomienne, E Suc, F Rigal-Huguet, C Gardin, A Delmer, E Archimbaud, H Tilly, M Janvier

Blood (1993) 82 (12): 3560–3563.

https://doi.org/10.1182/blood.V82.12.3560.3560

Published: 1993

Journal Articles

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

P Fenaux, MC Le Deley, S Castaigne, E Archimbaud, C Chomienne, H Link, A Guerci, M Duarte, MT Daniel, D Bowen

Blood (1993) 82 (11): 3241–3249.

https://doi.org/10.1182/blood.V82.11.3241.3241

Published: 1993

Journal Articles

Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells [see comments]

L Delva, M Cornic, N Balitrand, F Guidez, JM Miclea, A Delmer, F Teillet, P Fenaux, S Castaigne, L Degos

Blood (1993) 82 (7): 2175–2181.

https://doi.org/10.1182/blood.V82.7.2175.2175

Published: 1993

Journal Articles

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, T Lamy, H Tilly, A Guerci, F Maloisel

Blood (1992) 80 (9): 2176–2181.

https://doi.org/10.1182/blood.V80.9.2176.2176

Published: 1992

Journal Articles

A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia

S Castaigne, N Balitrand, H de The, A Dejean, L Degos, C Chomienne

Blood (1992) 79 (12): 3110–3115.

https://doi.org/10.1182/blood.V79.12.3110.3110

Published: 1992

Journal Articles

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

S Castaigne, C Chomienne, MT Daniel, P Ballerini, R Berger, P Fenaux, L Degos

Blood (1990) 76 (9): 1704–1709.

https://doi.org/10.1182/blood.V76.9.1704.1704

Published: 1990

Journal Articles

All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship

C Chomienne, P Ballerini, N Balitrand, MT Daniel, P Fenaux, S Castaigne, L Degos

Blood (1990) 76 (9): 1710–1717.

https://doi.org/10.1182/blood.V76.9.1710.1710

Published: 1990

Journal Articles

Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft

JP Fermand, Y Levy, J Gerota, M Benbunan, JM Cosset, S Castaigne, M Seligmann, JC Brouet

Blood (1989) 73 (1): 20–23.

https://doi.org/10.1182/blood.V73.1.20.20

Published: 1989

Journal Articles

c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia

P Lehn, F Sigaux, D Grausz, P Loiseau, S Castaigne, L Degos, G Flandrin, F Dautry

Blood (1986) 68 (4): 967–970.

https://doi.org/10.1182/blood.V68.4.967.967

Published: 1986

Journal Articles

Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment

G Flandrin, F Sigaux, S Castaigne, C Billard, M Aguet, M Boiron, E Falcoff, L Degos

Blood (1986) 67 (3): 817–820.

https://doi.org/10.1182/blood.V67.3.817.817

Published: 1986

Journal Articles

Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells

C Billard, F Sigaux, S Castaigne, F Valensi, G Flandrin, L Degos, E Falcoff, M Aguet

Blood (1986) 67 (3): 821–826.

https://doi.org/10.1182/blood.V67.3.821.821

Published: 1986

Journal Articles

Expression of vimentin intermediate filament cytoskeleton in acute nonlymphoblastic leukemias

K Dellagi, A Tabilio, MM Portier, W Vainchenker, S Castaigne, J Guichard, J Breton-Gorius, JC Brouet

Blood (1985) 65 (6): 1444–1452.

https://doi.org/10.1182/blood.V65.6.1444.bloodjournal6561444

Published: 1985

Journal Articles

Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease

F Calvo, S Castaigne, F Sigaux, M Marty, L Degos, M Boiron, G Flandrin

Blood (1985) 65 (1): 115–119.

https://doi.org/10.1182/blood.V65.1.115.115

Published: 1985

Journal Articles

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

S Castaigne, MT Daniel, H Tilly, P Herait, L Degos

Blood (1983) 62 (1): 85–86.

https://doi.org/10.1182/blood.V62.1.85.85

Published: 1983

NARROW

Outcome of Relapsed AML Patients Aged between 50 and 70: The ALFA Group Experience (ALFA 9801 Study).

Trisomy 4, a New Chromosomal Abnormality in Waldenstrom’s Macroglobulinemia.

Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials).

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia [see comments]

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]

Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells

Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells [see comments]

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship

Treatment of aggressive multiple myeloma by high-dose chemotherapy and total body irradiation followed by blood stem cells autologous graft

c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia

Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatment

Treatment of hairy cell leukemia with recombinant alpha interferon: II. In vivo down-regulation of alpha interferon receptors on tumor cells

Expression of vimentin intermediate filament cytoskeleton in acute nonlymphoblastic leukemias

Intensive chemotherapy of hairy cell leukemia in patients with aggressive disease

Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only